FTO-IN-3

CAS No. 2585198-87-2

FTO-IN-3( —— )

Catalog No. M28284 CAS No. 2585198-87-2

FTO-IN-3 is a FTO inhibitor that impair self-renewal in glioblastoma stem cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 295 Get Quote
10MG 475 Get Quote
25MG 761 Get Quote
50MG 1017 Get Quote
100MG 1377 Get Quote
200MG 1782 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    FTO-IN-3
  • Note
    Research use only, not for human use.
  • Brief Description
    FTO-IN-3 is a FTO inhibitor that impair self-renewal in glioblastoma stem cells.
  • Description
    FTO-IN-3 is a FTO inhibitor that impair self-renewal in glioblastoma stem cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Antibacterial|S. aureus|E. coli
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2585198-87-2
  • Formula Weight
    258.3
  • Molecular Formula
    C12H10N4OS
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (387.15 mM)
  • SMILES
    COc(nc1)ncc1-c(cc1)cc2c1nc(N)s2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Alyar, S., et al. Quantitative structure–activity relationships studies for prediction of antimicrobial activity of synthesized disulfonamide derivatives. Med Chem Res 20, 175–183 (2011).
molnova catalog
related products
  • KRN-633

    KRN-633 is an effective VEGFR inhibitor. The IC50s of KRN-633 for VEGFR1, VEGFR2, and VEGFR3 is 170, 160 and 125 nM, respectively.

  • CL 277082

    CL 277082 (Ddpmhu) is an acyl coenzyme A:cholesterol O-acyltransferase inhibitor that inhibits granuloma tissue ACAT activity.

  • Epoxomicin

    Epoxomicin is a selective proteasome inhibitor with anti-inflammatory activity, inhibits primarily the CH-L activity of the 20S proteasome.